Skip to main content
Clinical Trials/IRCT20160523028008N31
IRCT20160523028008N31
Recruiting
Phase 2

Investigating the effects of methylphenidate and atomoxetine on emotional intelligence, excutive function and self-efficacy of 12-18-year-old adolescents withThe effect of methylphenidate and automoxetine on emotional intelligence, executive function and self-efficacy of adolescents aged 12 to 18 years with Attention Deficit Hyperactivity Disorder (ADHD)

Hamedan University of Medical Sciences0 sites76 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hamedan University of Medical Sciences
Enrollment
76
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Consent to participation in the study by parents
  • Ages 12 to 18 years
  • Suffering from Attention Deficit Hyperactivity Disorder (ADHD)

Exclusion Criteria

  • The existence of a range of psychotic disorders
  • Autism spectrum disorders
  • Severe physical illnesses
  • intellectual disability

Outcomes

Primary Outcomes

Not specified

Similar Trials